Global Physician Dispensed Cosmeceuticals Market Size By Product Type (Skin care products, Hair care products), By Application (Hospital Pharmacy, Retail Pharmacy), By Geographic Scope And Forecast
의사 조제 코스메슈티컬 시장 규모와 전망
의사 조제 코스메슈티컬 시장 규모는 2024년에 95억 9,000만 달러로 평가되었고, 2026-2032년 8.98%의 연평균 복합 성장률(CAGR)로 성장하여 2032년에는 190억 8,000만 달러에 이를 것으로 예측됩니다.
미용의 본질과 전망에 대한 인식이 높아지고, 안티에이징에 대한 인식이 높아짐에 따라 의사 처방 화장품 시장의 성장을 가속할 것으로 보입니다. 의사 처방 화장품의 안전성과 효능에 대한 지식 증가, 노화로 인한 기미와 여드름 흉터 감소, 다양한 피부 문제에 대한 구체적인 해결책을 찾는 사용자의 기질 증가 등의 요인이 예측 기간 동안 의사 처방 화장품 시장의 성장을 더욱 촉진할 것으로 예측됩니다. 촉진할 것으로 예측됩니다.
세계의 의사 조제 코스메슈티컬 시장 정의
코스메슈티컬은 약효성분을 함유한 화장품입니다. 이 제품들은 법적 검증이 필요하지 않습니다. 의사가 조제하는 화장품은 의학적으로 지시된 사업을 통해서만 구할 수 있는 화장품으로, 각질층 아래 피부에 실제 생물학적 작용을 일으키는 것을 목적으로 합니다. 이러한 코스메슈티컬을 조제하는 많은 의사들은 피부 건강 관련 진료 또는 전문 분야를 전문으로 하는 의사들이 많습니다. 의사 조제 코스메슈티컬에는 스킨케어, 아이케어, 헤어케어 제품 등이 있습니다.
이 제품들은 노화의 징후, 감염, 기타 개인적 외모를 위해 특별히 고안된 제품입니다. 의사 조제 코스메슈티컬은 의료적으로 지시된 사업체를 통해서만 구입할 수 있으며, 각질층 아래 피부에 실제 생물학적 작용을 하는 것을 목적으로 하는 제품을 말합니다. 의사 조제 코스메슈티컬에는 피부과 의사, 모발 전문의, 미용외과 의사 및 기타 의료 전문가가 발표한 약용 미용 제품이 포함됩니다.
세계의 의사 조제 코스메슈티컬 시장 개요
미용과 외모에 대한 중요성 증가와 노화 방지에 대한 인식이 높아짐에 따라 세계의 의사 조제 코스메슈티컬 시장 성장을 가속할 것으로 예상되는 주요 요인입니다. 또한, 의사 조제 코스메슈티컬의 안전성과 효능에 대한 인식 증가와 신제품 출시도 세계 시장 성장에 기여하는 또 다른 요인으로 작용하고 있습니다.
또한, 의사 조제 코스메슈티컬은 일반 OTC 제품보다 피부에 더 깊숙이 침투하는 맞춤형 제품입니다.
이러한 제품들은 피부 깊숙이 침투하여 조기에 더 나은 결과를 가져다주며, 이것이 이 시장의 성장의 주요 요인으로 작용하고 있습니다. 대부분의 피지션 라인은 의사, 피부 전문가, 과학자들에 의해 설계 및 제조되며, 이들은 수년 동안 성분을 연구하고 자신의 클리닉에서 이를 실행하여 의도한 대상을 치료하기 위해 성분을 연구해 왔습니다. 또한, 미용과 외모의 중요성 증가, 노화 방지에 대한 인식 증가, 의사 조제 코스메슈티컬의 안전성과 효능에 대한 인식 증가도 시장 성장의 요인으로 작용하고 있습니다.
목차
제1장 세계의 의사 조제 코스메슈티컬 시장 서론
제2장 주요 요약
제3장 VERIFIED MARKET RESEARCH의 조사 방법
- 데이터 마이닝
- 밸리데이션
- 1차 자료
- 데이터 소스 리스트
제4장 세계의 의사 조제 코스메슈티컬 시장 전망
- 개요
- 시장 역학
- Porter's Five Forces 모델
- 밸류체인 분석
제5장 세계의 의사 조제 코스메슈티컬 시장 : 제품 유형별
- 개요
- 스킨케어 제품
- 헤어케어 제품
- 아이케어 제품
제6장 세계의 의사 조제 코스메슈티컬 시장 : 용도별
제7장 세계의 의사 조제 코스메슈티컬 시장 : 지역별
제8장 세계의 의사 조제 코스메슈티컬 시장 경쟁 구도
제9장 기업 개요
- Johnson & Johnson
- Allergan plc
- Procter & Gamble Co.
- Jan Marini Skin Research, Inc.
- L'Oreal S.A.
- Bausch Health Companies Inc.
- Unilever plc
- ZO Skin Health Inc.
- Obagi Cosmeceuticals LLC
- Merz Pharma
제10장 주요 개발
- 제품 출시 및 개발
- 인수합병(M&A)
- 사업 확대
- 파트너십 및 제휴
제11장 부록
LSH
Physician Dispensed Cosmeceuticals Market Size And Forecast
Physician Dispensed Cosmeceuticals Market size was valued at USD 9.59 Billion in 2024 and is projected to reach USD 19.08 Billion by 2032, growing at a CAGR of 8.98% from 2026 to 2032.
The growing of essence of beauty and outlook, and the increasing consciousness about anti-aging, will encourage the growth of the Physician Dispensed Cosmeceuticals Market. Factors such as the growing knowledge about the security and effectiveness of Physician Dispensed Cosmeceuticals and escalating disposition of users towards a certain solution to diverse skin problems about age spot or acne spot reduction are anticipated to further propel the growth of the Physician Dispensed Cosmeceuticals Market during the forecast period.
Global Physician Dispensed Cosmeceuticals Market Definition
Cosmeceuticals are cosmetics that consist of medicinal properties. These products do not require any legal verification. Physician Dispensed Cosmeceuticals are cosmetic products that are only available through a medically directed business and are geared towards creating actual biological actions on the skin below the stratum corneum. There are many physicians who choose to dispense these cosmeceuticals whose practices or specialties involve skin health. Physician Dispensed Cosmeceuticals involve the products such as skin care, eye care, hair care products, and others.
These products are specially designed to target the signs of aging, infections, and other personal appearances. Physician Dispensed Cosmeceuticals refer to products that are only available through a medically directed business and are geared towards creating actual biological actions on the skin below the stratum corneum. Physician Dispensed Cosmeceuticals include medicated aesthetic products referred by dermatologists, trichologists, cosmetic surgeons, and allied medical professionals.
Global Physician Dispensed Cosmeceuticals Market Overview
Rising importance regarding beauty and appearance and increasing awareness about anti-aging are the primary factors expected to fuel the growth of the Global Physician Dispensed Cosmeceuticals Market. Furthermore, increasing awareness regarding the safety and efficacy of physician-dispensed cosmeceuticals and new product launches are other factors contributing to the growth of the global market.
Moreover, Physician Dispensed Cosmeceuticals are custom-made products that penetrate deeper into the skin than normal OTC products.
As these products are deeply penetrated, it provides early and better results which is the prime factor responsible for the growth of this market. Most Physician lines are designed and formulated by physicians, skin professionals, and scientists who have researched ingredients for many years and put them into action in their own practices to treat intended targets. Additionally, the increasing importance of beauty and appearance, growing awareness about anti-aging, and increasing awareness about the safety and efficacy of physician-dispensed cosmeceuticals are the other factors that are contributing to the growth of the market.
Global Physician Dispensed Cosmeceuticals Market: Segmentation Analysis
The Global Physician Dispensed Cosmeceuticals Market is segmented on the basis of Product Type, Application, and Geography.
Physician Dispensed Cosmeceuticals Market, By Product Type
- Skin care products
- Hair care products
- Eye care products
Based on Product Type, the market is bifurcated into Skin care products, Hair care products, and Eye care products. The skincare products segment accounted for a prominent share of the Global Physician Dispensed Cosmeceuticals Market in 2022, as the nature of cosmeceuticals demanded by consumers is largely to treat dermatological conditions. Increasing awareness about personal maintenance among the geriatric population and changing attitudes of middle-aged and geriatric populations in developing countries have fuelled the demand for cosmeceuticals in order to eliminate the outward signs of aging.
Physician Dispensed Cosmeceuticals Market, By Application
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
Based on the Application, the market is bifurcated into Hospital Pharmacy, Retail Pharmacy, and Online Sales.
Physician Dispensed Cosmeceuticals Market, By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- On the basis of Regional Analysis, The Global Physician Dispensed Cosmeceuticals Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the Asia Pacific region is expected to grow significantly over the forecast period. A growing preference to behold long-lasting youthful appearance and beauty is driving the demand for effective physician-dispensed cosmeceuticals in the region. Furthermore, the growing focus of key market players on expansion in Asia Pacific countries, the huge customer base in the region, and rising awareness about physician-dispensed cosmeceuticals will also drive the market in the Asia Pacific.
Key Players
The "Global Physician Dispensed Cosmeceuticals Market" study report will provide valuable insight emphasizing the global market. The major players in the market are Johnson & Johnson, Allergan plc, Procter & Gamble Co., Jan Marini Skin Research, Inc., L'Oreal S.A., Bausch Health Companies Inc., Unilever plc, ZO Skin Health Inc., Merz Pharma, and Obagi Cosmeceuticals LLC.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.
Key Developments
- In 2019, Galderma, a leading player in the physician-dispensed cosmeceuticals market, announced a partnership with Colorescience, a cosmetics company that specializes in mineral-based sunscreens and other skincare products. The partnership aimed to offer a wider range of skincare options to patients and consumers.
- In October 2021, Huons Biopharma signed a contract worth 97.2 billion won with German-based pharmaceutical company Haemato Pharm to distribute its botulinum toxin product exclusively to the European market. Thus, such instances show an increase in demand for physician-dispensed cosmeceuticals, which is ultimately driving market growth.
- Ace Matrix Analysis
- The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into Active, Cutting Edge, Emerging, and Innovators categories.
- Market Attractiveness
- The image of market attractiveness provided further helps to get information about the region leading in the Global Physician Dispensed Cosmeceuticals Market. We cover the major impacting factors driving the industry growth in the given region.
- Porter's Five Forces
- The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Physician Dispensed Cosmeceuticals Market, gauge the attractiveness of a particular sector, and assess investment possibilities.
TABLE OF CONTENTS
1 INTRODUCTION OF GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET
- 1.1 Overview of the Market
- 1.2 Scope of Report
- 1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List of Data Sources
4 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET OUTLOOK
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
5 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY PRODUCT TYPE
- 5.1 Overview
- 5.2 Skin care products
- 5.3 Hair care products
- 5.4 Eye care products
6 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY APPLICATION
- 6.1 Overview
- 6.2 Hospital Pharmacy
- 6.3 Retail Pharmacy
- 6.4 Online Sales
7 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET, BY GEOGRAPHY
- 7.1 Overview
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
- 7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa
8 GLOBAL PHYSICIAN DISPENSED COSMECEUTICALS MARKET COMPETITIVE LANDSCAPE
- 8.1 Overview
- 8.2 Company Market Ranking
- 8.3 Key Development Strategies
9 COMPANY PROFILES
- 9.1 Johnson & Johnson
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
- 9.2 Allergan plc
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
- 9.3 Procter & Gamble Co.
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
- 9.4 Jan Marini Skin Research, Inc.
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
- 9.5 L'Oreal S.A.
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
- 9.6 Bausch Health Companies Inc.
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
- 9.7 Unilever plc
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
- 9.8 ZO Skin Health Inc.
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
- 9.9 Obagi Cosmeceuticals LLC
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
- 9.10 Merz Pharma
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments
10 KEY DEVELOPMENTS
- 10.1 Product Launches/Developments
- 10.2 Mergers and Acquisitions
- 10.3 Business Expansions
- 10.4 Partnerships and Collaborations
11 Appendix
